Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers. The company operates through two reportable segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications; and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
Last trade$18.13
Day change$0.00 (0.00%)
Day range$18.10 – $18.30
Volume679,011
Market cap$770M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$769.86M
Price / earnings
34.84×
Price / book
1.55×
Price / sales
0.89×
EV / sales
1.18×
EV / EBITDA
10.23×
Profitability
Earnings per share
$0.52
Return on assets
2.01%
Return on equity
4.45%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.7×
Current ratio
3.38×
Quick ratio
1.53×
Cash ratio
0.53×
Cash flow
Price / cash flow
68.13×
Price / free cash flow
—
Free cash flow
-$20.2M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for VREX, quarterly periods
Line item
Q3 FY2026 Jul 3, 2026
Q2 FY2026 Apr 3, 2026
Q1 FY2026 Jan 2, 2026
Q4 FY2025 Oct 3, 2025
Q3 FY2025 Jul 4, 2025
Q2 FY2025 Apr 4, 2025
Q1 FY2025 Jan 3, 2025
Q4 FY2024 Sep 27, 2024
Revenue
$210.5M
$216M
$209.6M
$228.9M
$203M
$212.9M
$199.8M
$205.7M
Cost of revenue
$133.8M
$143.4M
$139.8M
$151.1M
$135.5M
$136.2M
$131.3M
$138.6M
Gross profit
$76.7M
$72.6M
$69.8M
$77.8M
$67.5M
$76.7M
$68.5M
$67.1M
Selling, general and administrative
$30.6M
$36M
$32.7M
$34M
$32.9M
$32.6M
$33.8M
$34.3M
Research and development
$23.3M
$22.2M
$21.7M
$24.2M
$21.4M
$22M
$23.5M
$21.9M
Total operating expenses
$53.9M
$58.2M
$54.4M
$58.2M
$148.2M
$54.6M
$57.3M
$56.2M
Operating income
$22.8M
$14.4M
$15.4M
$19.6M
-$80.7M
$22.1M
$11.2M
$10.9M
Interest expense
-$5.8M
-$17.2M
-$7.9M
-$7.9M
-$9.4M
-$10.2M
-$8M
-$7.6M
Income before taxes
$16.2M
-$6.4M
$3.8M
$14.1M
-$86.6M
$10.8M
$2.5M
$2.5M
Income taxes
$300K
$1.6M
$1.4M
$1.9M
$2.5M
$3.7M
$2.6M
$53.5M
Net income
$15.9M
-$8M
$2.4M
$12.2M
-$89.1M
$7.1M
-$100K
-$51M
Net income attributable to common shareholders
$15.7M
-$8.1M
$2.3M
$12.2M
-$89.1M
$6.9M
-$300K
-$51.1M
EBITDA
$29.8M
$21.2M
$22.2M
$26.3M
$20M
$28.7M
$18.3M
$17.5M
Basic earnings per share
$0.37
-$0.19
$0.06
$0.29
-$2.15
$0.17
-$0.01
-$1.25
Diluted earnings per share
$0.37
-$0.19
$0.05
$0.38
-$2.15
$0.17
-$0.01
-$1.27
Recent news
Company coverage with links to the original publishers.
Monteverde & Associates PC, a class action securities firm, is investigating four merger deals to determine if they represent fair value for shareholders: Bowman Consulting Group's sale to Bernhard Capital Partners ($43.00/share), DoubleVerify Holdings' sale to Nielsen Holdings ($13.60/share), Varex Imaging's sale to Teledyne Technologies ($18.90/share), and MarineMax's sale to Francisco Partners ($53.00/share). The firm is soliciting shareholders to evaluate whether these proposed transactions are fair.
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed mergers and acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers. The investigations cover Varex Imaging's sale to Teledyne Technologies, Bowman Consulting's sale to Bernhard Capital Partners, Nathan's Famous' sale to Smithfield Foods, and Synlogic's merger with Caldera Therapeutics.
The dental digital X-ray market is expected to grow from $4 billion in 2024 to $6.57 billion by 2029, driven by factors like an aging population, rising dental diseases, and the adoption of advanced technologies. Key players like Dentsply Sirona and Envista are driving innovation in the market.
The global dental digital X-ray market is expected to grow from $3.1 billion in 2023 to $6.7 billion by 2033, at a CAGR of 7.68%. The growth is driven by rising awareness of digital X-ray technology, the shift towards preventive dentistry, and the increasing demand for cosmetic dentistry procedures.
VAREX IMAGING (VREX) delivered earnings and revenue surprises of -30.43% and 0.54%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.